Company
Therapeutic Areas
Our Pipeline
News
Careers
Contact Us
Select Year
2024
2023
2023.11.13
A Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia
2023.10.25
Optimized Artificial miRNAs Delivered by AAV9 Dramatically Improve Survival, Respiratory and Motor Functions of SOD1G93A-ALS Mice
2023.08.13
Voltage Gated Potassium Channel Activator for Resistant Epilepsy
About Us
Mission & Culture
Leadership Team
Depression
Schizophrenia
Neurological Disorders
Pipeline
Clinical Trials
Publications
Copyright © 2025 NeuShen Therapeutics, Inc. All rights reserved.